Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
HIP2105
/
Hanmi
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
HIP2105
/
Hanmi
Trial completion:
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
(clinicaltrials.gov) - Oct 25, 2023
P1
, N=48, Completed,
Sponsor: Hanmi Pharmaceutical Company Limited
Recruiting --> Completed
||
||||||||
HIP2105
/
Hanmi
New P1 trial:
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
(clinicaltrials.gov) - Jul 22, 2021
P1
, N=48, Recruiting,
Sponsor: Hanmi Pharmaceutical Company Limited